RadNet, Inc. (RDNT)
RDNT Stock Price Chart
Explore RadNet, Inc. interactive price chart. Choose custom timeframes to analyze RDNT price movements and trends.
RDNT Company Profile
Discover essential business fundamentals and corporate details for RadNet, Inc. (RDNT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
3 Jan 1997
Employees
11.00k
Website
https://www.radnet.comCEO
Howard G. Berger
Description
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
RDNT Financial Timeline
Browse a chronological timeline of RadNet, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Aug 2026
EPS estimate is $0.18, while revenue estimate is $610.01m.
Earnings released on 11 May 2026
EPS came in at -$0.28 falling short of the estimated -$0.14 by -100.00%, while revenue for the quarter reached $575.60m , beating expectations by +3.17%.
Earnings released on 2 Mar 2026
EPS came in at $0.23 surpassing the estimated $0.19 by +21.05%, while revenue for the quarter reached $547.71m , beating expectations by +6.00%.
Earnings released on 9 Nov 2025
EPS came in at $0.20 falling short of the estimated $0.22 by -10.27%, while revenue for the quarter reached $522.87m , beating expectations by +5.74%.
Earnings released on 10 Aug 2025
EPS came in at $0.31 surpassing the estimated $0.17 by +82.35%, while revenue for the quarter reached $498.23m , beating expectations by +0.95%.
Earnings released on 11 May 2025
EPS came in at -$0.35 falling short of the estimated -$0.17 by -105.88%, while revenue for the quarter reached $471.40m , beating expectations by +6.41%.
Earnings released on 27 Feb 2025
EPS came in at $0.22 surpassing the estimated $0.21 by +4.76%, while revenue for the quarter reached $477.10m , beating expectations by +3.85%.
Earnings released on 10 Nov 2024
EPS came in at $0.18 surpassing the estimated $0.14 by +32.55%, while revenue for the quarter reached $461.14m , beating expectations by +6.28%.
Earnings released on 7 Aug 2024
EPS came in at $0.16 matching the estimated $0.16, while revenue for the quarter reached $459.71m , beating expectations by +4.84%.
Earnings released on 8 May 2024
EPS came in at $0.07 surpassing the estimated -$0.09 by +177.78%, while revenue for the quarter reached $431.71m , beating expectations by +2.37%.
Earnings released on 29 Feb 2024
EPS came in at $0.20 surpassing the estimated $0.11 by +81.82%, while revenue for the quarter reached $420.38m , missing expectations by -0.13%.
Earnings released on 8 Nov 2023
EPS came in at $0.14 surpassing the estimated $0.06 by +133.33%, while revenue for the quarter reached $401.97m , missing expectations by -2.46%.
Earnings released on 8 Aug 2023
EPS came in at $0.24 surpassing the estimated $0.07 by +242.86%, while revenue for the quarter reached $403.72m , beating expectations by +3.33%.
Earnings released on 9 May 2023
EPS came in at -$0.08 falling short of the estimated -$0.07 by -14.29%, while revenue for the quarter reached $390.56m , beating expectations by +5.18%.
Earnings released on 28 Feb 2023
EPS came in at $0.11 falling short of the estimated $0.15 by -26.67%, while revenue for the quarter reached $383.88m , beating expectations by +10.54%.
Earnings released on 9 Nov 2022
EPS came in at $0.09 falling short of the estimated $0.16 by -43.75%, while revenue for the quarter reached $350.04m , beating expectations by +0.32%.
Earnings released on 9 Aug 2022
EPS came in at $0.15 surpassing the estimated $0.05 by +200.00%, while revenue for the quarter reached $354.38m , beating expectations by +1.56%.
Earnings released on 9 May 2022
EPS came in at -$0.15 falling short of the estimated -$0.00 by -4.60k%, while revenue for the quarter reached $341.77m , beating expectations by +2.49%.
Earnings released on 1 Mar 2022
EPS came in at $0.13 falling short of the estimated $0.19 by -31.58%, while revenue for the quarter reached $333.15m , missing expectations by -3.33%.
Earnings released on 8 Nov 2021
EPS came in at $0.21 surpassing the estimated $0.20 by +5.00%, while revenue for the quarter reached $332.69m , missing expectations by -2.51%.
Earnings released on 9 Aug 2021
EPS came in at $0.27 surpassing the estimated $0.14 by +92.86%, while revenue for the quarter reached $333.92m , beating expectations by +11.73%.
RDNT Stock Performance
Access detailed RDNT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
